KOREA PHARMA Revenue

In the year 2025, KOREA PHARMA had annual revenue of 87.60B KRW with 7.78% growth. KOREA PHARMA had revenue of 19.43B in the quarter ending December 31, 2025, a decrease of -11.44%.

Revenue

87.60B

Revenue Growth

+7.78%

P/S Ratio

1.46

Revenue / Employee

653.74M

Employees

134

Market Cap

128.15B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.60B	6.32B	7.78%
Dec 31, 2024	81.28B	-1.96B	-2.36%
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HYUNDAI BIOLAND	130.51B
WITHUS PHARMACEUTICAL Co.,LTD.	106.44B
DongKoo Bio & Pharma	242.69B
PHARMARESEARCH BIO	178.19M
Kyung Dong Pharmaceutical	196.27B
Organoidsciences	2.41B
H.PIO	258.19B
Daehan Nupharm	202.40B

Revenue Rankings